Back to "Both CD and UC patient samples showed di..."

Strong Support

descriptive

History

In people with inflammatory bowel disease, specific proteins and enzymes in colon tissue are found at lower levels, while other molecular markers associated with tissue remodeling are higher, similar...

Pro

Against

Mechanism

Synthesis from 1 study

How it works

When a key protein called IPMK is missing, it stops making a molecule that turns on a cleanup enzyme. Without this enzyme, a chemical tag builds up on DNA and turns on destructive proteins that break apart the seal between gut cells. This lets harmful substances leak through, worsening inflammation.

Most probable mechanism

In Simple Terms

A protein called IPMK produces a molecule called InsP6 in gut cells, which turns on another protein called HDAC3. When HDAC3 is active, it removes a chemical tag from DNA that normally keeps certain destructive enzymes turned on. Without this tag, those enzymes stay silent. But when IPMK is low, InsP6 drops, HDAC3 turns off, the tag builds up, and the destructive enzymes are made in large amounts. These enzymes break down the glue that holds gut cells together, letting harmful substances leak through and worsen inflammation.

Causal chain

IPMK binds to HDAC3 on chromatin and catalyzes the synthesis of inositol hexakisphosphate (InsP6) from precursor inositol phosphates

Verified by multiple studies

which leads to

InsP6 directly binds to HDAC3 and recruits the DAD domain of the NCoR1/2 corepressor complex, enabling HDAC3 to become enzymatically active

Verified by multiple studies

which leads to

Activated HDAC3 removes acetyl groups from histone H4 at lysine 16 (H4K16) at the promoter regions of matrix metalloproteinase genes

Verified by multiple studies

which leads to

Deacetylation of H4K16 suppresses transcription of matrix metalloproteinase genes, including MMP3 and MMP13

Verified by multiple studies

which leads to

Reduced expression of MMP3 and MMP13 prevents degradation of tight junction proteins such as ZO-1 and occludin

Verified by multiple studies

which leads to

Intact tight junctions maintain low paracellular permeability, preserving the intestinal barrier and preventing systemic inflammation

Verified by multiple studies

Evidence from Studies

Supporting (1)

Community contributions welcome

Phytic acid (InsP6) activates HDAC3 epigenetic axis to maintain intestinal barrier function

Randomized Controlled Trial

Animal & In Vitro

2026 Feb 9

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Phytic acid (InsP6) activates HDAC3 epigenetic axis to maintain intestinal barrier function

Score: 18

DOI: 10.1038/s41467-026-68994-0

Similar Assertions

In individuals with inflammatory bowel disease, specific proteins and chemical modifications in intestinal tissue are altered in a pattern that matches changes seen in mice genetically engineered to lack the IPMK protein.

96%

In people with inflammatory bowel disease, specific proteins and chemical modifications in intestinal tissue are altered in a pattern that matches changes seen in mice genetically engineered to lack the IPMK protein.

93%

When the IPMK gene is disabled in gut lining cells of mice, it leads to lower levels of a specific molecule (InsP6), reduced activity of an enzyme (HDAC3), and changes in gene regulation that increase the production of enzymes that break down structural barriers. This results in a leakier intestinal barrier.

81%

In mouse intestinal cells, removing the IPMK gene lowers a specific molecule called InsP6, which interferes with a protein complex that controls gene activity. This causes changes in gene expression that lead to the breakdown of proteins holding intestinal cells together, resulting in increased leakage through the intestinal barrier.

80%

Removing the IPMK gene from intestinal cells in mice decreases HDAC3 activity, which leads to changes in gene expression that weaken the intestinal barrier.

80%